While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
Profits are valuable, but they’re not everything. At StockStory, we help you identify the companies that have real staying power. That said, here are two profitable companies that leverage their financial strength to beat the competition and one that may struggle to keep up.
One Stock to Sell:
RLI (RLI)
Trailing 12-Month GAAP Operating Margin: 29.1%
Founded in 1965 and named after its original focus on "replacement lens insurance" for contact lens wearers, RLI (NYSE:RLI) is a specialty insurance company that underwrites property, casualty, and surety products through wholesale brokers, independent agents, and carrier partnerships.
Why Is RLI Not Exciting?
- Day-to-day expenses have swelled relative to revenue over the last five years as its pre-tax profit margin fell by 10.4 percentage points
- Earnings per share lagged its peers over the last two years as they only grew by 15% annually
- Muted 8.4% annual book value per share growth over the last two years shows its capital generation lagged behind its insurance peers
RLI is trading at $51.50 per share, or 2.6x forward P/B. Dive into our free research report to see why there are better opportunities than RLI.
Two Stocks to Watch:
Astrana Health (ASTH)
Trailing 12-Month GAAP Operating Margin: 2.5%
Formerly known as Apollo Medical Holdings until early 2024, Astrana Health (NASDAQ:ASTH) operates a technology-powered healthcare platform that enables physicians to deliver coordinated care while successfully participating in value-based payment models.
Why Are We Fans of ASTH?
- Market share has increased this cycle as its 51.5% annual revenue growth over the last two years was exceptional
- Notable projected revenue growth of 25.2% for the next 12 months hints at market share gains
- Earnings per share have massively outperformed its peers over the last five years, increasing by 15.9% annually
At $34.86 per share, Astrana Health trades at 12.7x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
BrightSpring Health Services (BTSG)
Trailing 12-Month GAAP Operating Margin: 2.7%
Founded in 1974, BrightSpring Health Services (NASDAQ:BTSG) offers home health care, hospice, neuro-rehabilitation, and pharmacy services.
Why Could BTSG Be a Winner?
- Annual revenue growth of 22.6% over the past two years was outstanding, reflecting market share gains this cycle
- Economies of scale give it more fixed cost leverage than its smaller competitors
- Forecasted revenue growth of 14% for the next 12 months indicates its momentum over the last two years is sustainable
BrightSpring Health Services’s stock price of $52.29 implies a valuation ratio of 28x forward P/E. Is now the time to initiate a position? See for yourself in our in-depth research report, it’s free.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.